Lv5
1224 积分 2024-04-20 加入
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
11天前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
11天前
已完结
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
11天前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
12天前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
12天前
已完结
CRISPR activation for SCN2A-related neurodevelopmental disorders
15天前
已完结
Specific loading of oncolytic VSV on CAR enhances CAR-T cell signaling and antitumor activity
22天前
已完结
In Vitro and in Vivo RNA Inhibition by CD9-HuR Functionalized Exosomes Encapsulated with miRNA or CRISPR/dCas9
26天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
26天前
已完结
Surface functionalization of exosomes for chondrocyte-targeted siRNA delivery and cartilage regeneration
29天前
已完结